LONDON STRATEGIC HEALTH AUTHORITY
4TH FLOOR, SOUTHSIDE, 105 VICTORIA STREET, LONDON, GREATER LONDON, SW1E 6QT See member list for this organisation
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 8980 | 10690 | 84.0% | |
| HF 4 | 2011 | 9832 | 11762 | 83.6% | |
| HF 4 | 2012 | 10348 | 12226 | 84.6% |
